Member Info for EmeraldCarrots

.

Wyndrum.

"I imagine a close of 22p or above will confirm a reversal is underway. The current support is 16.5p so close below that would suggest further falls".

Well the RNS of 19/04/2023 sent the sp to 29p so a decent spiker it is IMHO!

LOL!

Waiting.......

The next thing could be AGL receiving a takeover bid @ 84p a share.

Stranger things have happened.

For some reason I bought some more today.

Gut feeling. Made some good decisions recently. Maybe pure luck!

So I'm pretty pleased. Good day.

Likely to suffer some from profit taking tomorrow AM but we will see.

Up 13.5% over the pond as I type this.

Only a few mins old.

https://www.bbc.co.uk/news/business-65882032

Excellent news!

Or the players taking their profits have had their day and off we go up again??...........

WIZZ.......

Oh, and just sold some JET2 !

I'm sure we will see £30 a share fairly soon.

All IMHO.

Will they get a bid? I think so........

The demand to use Angle's Parsortix system to get he metastasized cancerous Breast cancer cell so you can test it must be huge. Surely it is/will be the "Gold Standard" to use to minitor whether a Breast cancer treatment is working, or not. If testing the cell finds that the treatment is not working it can be stopped and another treatment tried. Patients have a lot of side effects from these treatments I understand. Some will unfortunately be putting up with side effects when, unknown to them, the treatment is simply having no effect. May well save lives and WOULD CERTAINLY SAVE TIME, SUFFERING AND MONEY. Using a treatment that does not work is terrible not only because of it not working but time wasted will enable the cancer to spread further unabaited.

Investment from Big Pharma I believe could get the FDA clearance for numerous other cancers other than Breast.

I can't see why the market has not. yet anyway, reaslise the massive potential here.

Large Pharma Co's MUST, I SAY MUST be looking at what Angle Plc might be worth to them.

I await the bid.

It would need to be 80p a share plus to appease the investors that paid that in the last placing last July I shoul think.

All IMHO.

The demand to use Angle's Parsortix system to get he metastasized cancerous Breast cancer cell so you can test it must be huge. Surely it is/will be the "Gold Standard" to use to minitor whether a Breast cancer treatment is working, or not. If testing the cell finds that the treatment is not working it can be stopped and another treatment tried. Patients have a lot of side effects from these treatments I understand. Some will unfortunately be putting up with side effects when, unknown to them, the treatment is simply having no effect. May well save lives and WOULD CERTAINLY SAVE TIME, SUFFERING AND MONEY. Using a treatment that does not work is terrible not only because of it not working but time wasted will enable the cancer to spread further unabaited.

Investment from Big Pharma I believe could get the FDA clearance for numerous other cancers other than Breast.

I can't see why the market has not. yet anyway, reaslise the massive potential here.

Large Pharma Co's MUST, I SAY MUST be looking at what Angle Plc might be worth to them.

I await the bid.

It would need to be 80p a share plus to appease the investors that paid that in the last placing last July I shoul think.

All IMHO.

Push the price of oil up. Also Saudi want the oil price higher by all accounts. In the low $80's apparently.

The lower the sp goes......... and the cheaper I suspect Shell would have to pay to buy DELT.

So they are not in a rush?

All IMHO.

Https://www.reuters.com/business/aerospace-defense/airbus-a321xlr-delays-average-12-months-across-industry-qantas-2023-06-05/

A blood sample after starting cancer treatment you can analyse it to find out how effective the treatment is over the weeks/months of the treatment. If it's not working you can try another type of treatment.

Angle's Parsortix system enables you get the metastasized cancerous cell so you can test it.

It's only got FDA approval for Breast cancer at the moment, although that market in itself is huge and obviously World wide. A larger pharma Co. could buy angle and then put the investment in so the system can get FDA approval for other cancers. That IMHO woud give massive profits to whoever is bold enough to buy Angle Plc.

This is why I believe Angle Plc will get taken over.

All IMHO.

You should have another look at the presentation a few weeks back (see below).

Grail currently look for DNA fragments in the blood plasma to get the information they need.

https://www.youtube.com/watch?v=JEGA5EKP9h0

"The Galleri process looks for tiny fragments of tumour DNA circulating in you blood stream.".

If you read up on this because the fragments are older than an actual living cancer cell they cannot provide as up to date information as a live cell can...........................

Seems to me you can't get better information than having a live cancerous cell to examine. Fairly obvious.

Angle's Parsortix system lets you get exactly that.

Only a matter of time until a takeover bid IMHO.

Maybe it will be Grail making an offer?

Also see the excellect presentation from a few weeks back:-

https://www.youtube.com/watch?v=JEGA5EKP9h0

All IMHO.

"The Galleri process looks for tiny fragments of tumour DNA circulating in you blood stream.".

If you read up on this because the fragments are older than an actual living cancer cell they cannot provide as up to date information as a live cell can...........................

Seems to me you can't get better information than having a live cancerous cell to examine. Fairly obvious.

Angle's Parsortix system lets you get exactly that.

Only a matter of time until a takeover bid IMHO.

Maybe it will be Grail making an offer?

All IMHO.

Moab.

You post "The capture rate for intact cancer cells in early malignancy IS LIKELY to be exceedingly small, and as a screening test Parsortix is, sadly, OF NO VALUE. The Grail process, using fragments, seems to be improving in the early detection of suspected, or even unsuspected malignancy. I wonder whether AI might make this process even more accurate. But it will never supplant Parsortix as a means of careful analysis of all aspects of the cancer cell which is going to be of value in determining the correct therapeutic approach.".

You are posting as if you know what you are talking about but have done it in such a way (using the words "likely" etc) to cover yourself. The "OF NO VALUE" is probably illegal to post. You should not post things you are assuming without making it clear. I suspect you are short Angle Plc. Shame on you.

All IMHO.